Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma

Jiangshan Lian; Xiaolin Zhang; Yingfeng Lu; Shaorui Hao; Zhe Zhang; Yida Yang

doi:10.2174/1386207322666190404151020

Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma

Comb Chem High Throughput Screen. 2019;22(3):201-206. doi: 10.2174/1386207322666190404151020.

Authors

Jiangshan Lian¹, Xiaolin Zhang², Yingfeng Lu¹, Shaorui Hao¹, Zhe Zhang³, Yida Yang¹

Affiliations

¹ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
² Shanghai Public Health Clinical Center, Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, China.
³ Urology Department, The First Affiliated Hospital of Zhejiang University, School of Medicine, Zhejiang University, Hangzhou 310003, China.

PMID: 30947664
DOI: 10.2174/1386207322666190404151020

Abstract

Objective: To investigate the expression of long-chain non-coding RNA MINCR (LncRNAMINCR) and Cyclin-Dependent Kinase 2 (CDK2) mRNA in primary hepatocellular carcinoma, and to analyze the relationship between its expression and clinical pathological parameters and prognosis of hepatocellular carcinoma.

Methods: Seventy-five surgically resected primary hepatocellular carcinoma tissues and paracancerous tissues were selected. Real-time PCR was used to detect the expression of LncRNA-MINCR and CDK2 mRNA in hepatocellular carcinoma tissues and adjacent tissues. The relationship of clinicopathological parameters and prognosis between hepatocellular carcinoma and LncRNA-MINCR and CDK2 mRNA were analyzed. Pearson correlation coefficient describes the correlation between LncRNA-MINCR and CDK2 mRNA.

Results: The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma tissues was higher than that in the adjacent tissues [(5.51±0.62) vs (1.62±0.51), (4.52±0.73) vs (1.85±0.95), P<0.05]. The expression of LncRNA-MINCR in the primary hepatocellular carcinoma group was positively correlated with CDK2 mRNA (r=0.352, P<0.05), and the expression of LncRNA-MINCR in the paracancerous tissue group was not correlated with CDK2 mRNA (r=0.024, P>0.05). LncRNA-MINCR expression was associated with TNM staging, lymph node metastasis, and cirrhosis (P<0.05). CDK2 mRNA expression was associated with tumor diameter, TNM stage, lymph node metastasis, and serum alpha-fetoprotein levels (P<0.05). The 3-year survival rate of patients with high expression of LncRNAMINCR was lower than that of LncRNA-MINCR low expression group [53.49% vs 77.38%, 2=13.024, P<0.05). The 3-year survival rate of patients with high CDK2 mRNA expression was lower than that of CDK2 mRNA low expression group [51.29] % vs 80.38%, 2 = 10.15, P < 0.05].

Conclusion: The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma tissues increased significantly. The two play a synergistic role in the invasion, invasion and metastasis of hepatocarcinoma cells. High expression of LncRNA-MINCR and CDK2 mRNA indicates poor prognosis in patients with hepatocellular carcinoma.

Keywords: CDK2 mRNA; LncRNA-MINCR; Malignant tumor; clinicopathological parameters; gene expression; primary hepatocellular carcinoma; prognosis..

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Carcinoma, Hepatocellular / physiopathology*
Cyclin-Dependent Kinase 2 / genetics*
Female
Gene Expression Regulation, Neoplastic / genetics*
Humans
Liver Neoplasms / physiopathology*
Lymph Nodes / metabolism
Male
Middle Aged
Neoplasm Metastasis / physiopathology
Neoplasm Staging
Prognosis
RNA, Long Noncoding / metabolism*
RNA, Messenger / metabolism*
alpha-Fetoproteins / metabolism

Substances

RNA, Long Noncoding
RNA, Messenger
alpha-Fetoproteins
CDK2 protein, human
Cyclin-Dependent Kinase 2